Exposure to natalizumab during pregnancy and lactation is safe - No

Tietueen suppeat tiedot
dc.contributor.authorAiras Laura
dc.contributor.organizationfi=kliiniset neurotieteet|en=Clinical Neurosciences|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.74845969893
dc.converis.publication-id48670257
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/48670257
dc.date.accessioned2022-10-28T12:32:16Z
dc.date.available2022-10-28T12:32:16Z
dc.format.pagerange889
dc.format.pagerange891
dc.identifier.eissn1477-0970
dc.identifier.jour-issn1352-4585
dc.identifier.olddbid177132
dc.identifier.oldhandle10024/160226
dc.identifier.urihttps://www.utupub.fi/handle/11111/49383
dc.identifier.urnURN:NBN:fi-fe2021042825055
dc.language.isoen
dc.okm.affiliatedauthorAiras, Laura
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3112 Neurosciencesen_GB
dc.okm.discipline3112 Neurotieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeB1 Scientific Journal
dc.publisherSAGE PUBLICATIONS LTD
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumberARTN 1352458520917934
dc.relation.doi10.1177/1352458520917934
dc.relation.ispartofjournalMultiple Sclerosis
dc.relation.issue8
dc.relation.volume26
dc.source.identifierhttps://www.utupub.fi/handle/10024/160226
dc.titleExposure to natalizumab during pregnancy and lactation is safe - No
dc.year.issued2020

Tiedostot

Näytetään 1 - 1 / 1
Name:
1352458520917934.pdf
Size:
54.17 KB
Format:
Adobe Portable Document Format
Description:
Publisher's version
Lataa

Kokoelmat

Rinnakkaistallenteet